News

Bristol Myers tops revenue expectations on strength of older drugs, shares fall
Bristol Myers Squibb posted much better-than-expected second-quarter results on Thursday on strong sales of its best-selling ...
Bristol Myers Squibb Cuts Full-Year Adjusted View, but Raises Revenue Expectations
Bristol Myers Squibb trimmed its full-year adjusted earnings view as it reported lower second-quarter earnings due to a ...
Bristol-Myers Squibb (BMY) Gains FDA Nod for TYK2 Inhibitor Sotyktu
Bristol-Myers Squibb Company (NYSE:BMY) ranks among the best medical stocks to buy according to analysts. Bristol-Myers ...
Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors
Shares of Bristol Myers Squibb Co. BMY slid 5.81% to $43.31 Thursday, on what proved to be an all-around dismal trading ...
2BMY : Bristol-Myers Squibb Unusual Options Activity For July 31
Out of all of the special options we uncovered, 26 are puts, for a total amount of $1,771,839, and 16 are calls, for a total amount of $839,064. Taking into account the Volume and Open Interest on ...
TipRanks on MSN3d
Bristol-Myers Squibb’s New Study on Deucravacitinib: A Potential Game-Changer for Adolescent Psoriasis
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors
This was the stock's fifth consecutive day of losses.